Clinical Trial Demonstrates Significant Improvement for Women With Advanced or Recurrent Endometrial Cancer

United States News News

Clinical Trial Demonstrates Significant Improvement for Women With Advanced or Recurrent Endometrial Cancer
United States Latest News,United States Headlines
  • 📰 SciTechDaily1
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 68%

NRG Oncology NRG-GY018 study demonstrates significantly improved progression free survival outcomes for women with advanced or recurrent endometrial cancer with the addition of pembrolizumab to chemotherapy. NRG Oncology Phase III clinical trial, NRG-GY018, evaluating pembrolizumab in combination

Endometrial cancer is a type of cancer that starts in the lining of the uterus, called the endometrium. It is the most common type of uterine cancer. Symptoms can include abnormal vaginal bleeding, pelvic pain, and weight loss. The exact cause of endometrial cancer is not known, but certain factors such as obesity, hormonal imbalances, and a family history of cancer may increase the risk. Treatment options for endometrial cancer may include surgery, radiation therapy, and chemotherapy.

NRG Oncology Phase III clinical trial, NRG-GY018, evaluating pembrolizumab in combination with standard of care chemotherapy met its primary endpoint of progression free survival for the treatment of patients with stage III-IV or recurrent endometrial carcinoma, regardless of mismatch repair status.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

SciTechDaily1 /  🏆 84. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Implementing clinical trial data sharing requires training a new generation of biomedical researchers - Nature MedicineImplementing clinical trial data sharing requires training a new generation of biomedical researchers - Nature MedicineData sharing enhances the value of medical research and builds trust in clinical trials, but more biomedical researchers need to be trained in these approaches, which include meta-research, data science and ethical, legal and social issues.
Read more »

A new vaccine to fight fungal infections has passed clinical trialsA new vaccine to fight fungal infections has passed clinical trials'With its ability to address three different pathogens, this vaccine has the potential to revolutionize the way we approach invasive fungal infections.'
Read more »

Looking to binge on a new TV show? Try Kaleidoscope | Youth ViewsLooking to binge on a new TV show? Try Kaleidoscope | Youth ViewsKaleidoscope demonstrates the evolution of television.
Read more »

Stanley S. Schor, retired professor, biostatistics pioneer, clinical researcher, author, and veteran has died at 100Stanley S. Schor, retired professor, biostatistics pioneer, clinical researcher, author, and veteran has died at 100He was known for a his sense of humor, generosity, and intelligence. Friends called him 'one of the smartest, warmest, funniest persons we have known.'
Read more »

House Bill 6 trial: FBI agent to detail alleged pay-to-play scheme at Ohio StatehouseHouse Bill 6 trial: FBI agent to detail alleged pay-to-play scheme at Ohio StatehouseFBI's Blane Wetzel will take the stand Wednesday to detail how ex-Ohio House Speaker Larry Householder's return to power was fueled by FirstEnergy.
Read more »

Perjury trial against former NYC narcotics detective thrown out following error by prosecutorPerjury trial against former NYC narcotics detective thrown out following error by prosecutorA New York prosecutor failed to turn over evidence required for his defense, leading to a case being thrown out. The case was against a former NYC narcotics detective.
Read more »



Render Time: 2025-02-22 06:51:54